How Does Verzenio Work for Metastatic Breast Cancer? Verzenio is a type of medicine called a kinase inhibitor. Kinases are enzymes in the body that can send and receive signals to help your cells do ...
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the ...
Patients with HR-positive, HER2-negative high-risk early breast cancer tended to experience improved invasive disease and distant relapse-free survival after adding Verzenio to endocrine therapy.
Verzenio monotherapy provided clinical benefits to 33% of patients with HR-positive, HER2-negative breast cancer after prior CDK4/6 inhibitor therapy. The rAMBER study highlights Verzenio's potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results